Skip to content
OpenCapital
Get started

Sarepta Therapeutics, Inc. SRPT Elevidys — Revenue

Other product segments

Pmo Products
$236.54M—

Similar metrics at other companies

HRO
HROWIHEEZO — Revenue
$1.85M-64.6%
HRO
HROWVEVYE — Revenue
$20.95M-2.6%
ADMA Biologics logo
ADMARevenue
$114.49M-0.3%
DJT
DJTRevenue
$871.2K+6.1%
Helios Technologies logo
HLIOElectronics — Revenue
$89.2M+29.1%
Cal-Maine Foods logo
CALMRevenue
$666.95M-53.0%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.82B-63.1%
Enterprise value$1.56B-67.2%
P/S0.8×—

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s elevidys — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s elevidys — revenue?
Sarepta Therapeutics, Inc. (SRPT) reported elevidys — revenue of $101.97M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s elevidys — revenue changed year-over-year?
Sarepta Therapeutics, Inc.'s elevidys — revenue decreased by 72.8% year-over-year, from $374.99M to $101.97M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s elevidys — revenue?
Over 2 years (2023 to 2025), Sarepta Therapeutics, Inc.'s elevidys — revenue has grown at a 111.8% compound annual growth rate (CAGR), from $200.36M to $898.73M.
What does elevidys — revenue mean?
Represents the total gross revenue generated from the direct sale of the specific product or service to customers, excluding any sales-related taxes. This metric serves as a primary indicator of market adoption and commercial performance for the product line. It reflects the core top-line growth generated by the segment's commercial activities.